BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
BioInvent International and Bayer Pharma have extended their collaboration to develop antibodies from BioInvent's n-CoDeR libraries. As part of the deal, which is an extension of the 2008 license agreement, Bayer will broaden its access ...